ZC3H6 is a zinc finger CCCH-type protein localized to the nucleoplasm with annotated DNA-binding transcription repressor activity specific to RNA polymerase II, suggesting a role in negative regulation of transcription elongation [GO annotations]. However, direct functional characterization of ZC3H6 remains limited in the provided literature. ZC3H6 has been identified as a candidate gene in several disease contexts. In pediatric nasopharyngeal carcinoma, ZC3H6 mutations occur in 16.7% of cases, comparable to other frequently mutated genes in this malignancy 1. In primary Sjögren's syndrome, the circular RNA form (circ-ZC3H6) shows significantly elevated expression in minor salivary glands and plasma exosomes of affected patients, correlating with clinical features and immunoglobulin levels; combined with circ-IQGAP2, it demonstrated high discriminatory capacity (AUC 0.92-0.93) as a noninvasive diagnostic biomarker 2. Additionally, ZC3H6 was identified within a de novo chr2 deletion in a patient with spina bifida, though its specific contribution to neural tube development remains unclear 3. In drug-induced liver injury studies, ZC3H6 expression was upregulated under immunological stress with hepatotoxic compounds, suggesting potential involvement in immune-metabolic responses 4. These findings indicate ZC3H6 involvement in transcriptional regulation with potential relevance to cancer, autoimmune disease, and developmental pathology, though mechanistic details require further investigation.